Skip to main content
Top
Published in: CEN Case Reports 4/2019

01-11-2019 | Acute Kidney Injury | Case Report

Acute kidney injury in an adult patient with IgA nephropathy and chronic replicative Epstein–Barr virus infection

Authors: Yuya Sato, Kaito Furuyama, Takeshi Suzuki, Tomoyuki Tanaka, Ami Sato, Akira Iguchi, Kazuhiro Yoshita, Yumi Ito, Naofumi Imai, Hajime Yamazaki, Ichiei Narita

Published in: CEN Case Reports | Issue 4/2019

Login to get access

Abstract

Most of the adult population are infected with Epstein–Barr virus (EBV), but as EBV replication is usually under immune system control, the majority of individuals remain asymptomatic. On the other hand, some individuals continuously retain a high EBV antibody titer and a high EBV DNA load in their blood, suggesting a defect of EBV replication control. To date, only a limited number of reports have addressed the relationship between this chronic form of EBV infection and renal involvement. Here, we describe an 80-year-old woman who developed acute kidney injury shortly after an episode of mosquito bites, accompanied by a severe skin rash, which raised a suspicion of chronic EBV infection. She was subsequently diagnosed as having chronic replicative EBV infection. Renal biopsy revealed a diagnosis of IgA nephropathy with crescent formation. Although the relationship between IgA nephropathy and EBV infection has been discussed, no substantial understanding has yet emerged. The patient’s characteristic clinical course suggested that the renal failure may have been partly attributable to chronic EBV infection. This case suggests that physicians may need to consider the possibility that chronic EBV infection may affect the clinical course of IgA nephropathy, or exacerbate the disease.
Literature
1.
go back to reference Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis. 2005;192:1505–12.CrossRef Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis. 2005;192:1505–12.CrossRef
2.
go back to reference Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280–6.CrossRef Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280–6.CrossRef
3.
go back to reference Tatsuno K, Fujiyama T, Matsuoka H, et al. Clinical categories of exaggerated skin reactions to mosquito bites and their pathophysiology. J Dermatol Sci. 2016;82:145–52.CrossRef Tatsuno K, Fujiyama T, Matsuoka H, et al. Clinical categories of exaggerated skin reactions to mosquito bites and their pathophysiology. J Dermatol Sci. 2016;82:145–52.CrossRef
4.
go back to reference Ishihara S, Okada S, Wakiguchi H, et al. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol. 1997;54:276–81.CrossRef Ishihara S, Okada S, Wakiguchi H, et al. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol. 1997;54:276–81.CrossRef
5.
go back to reference Chiu TM, Lin YM, Wang SC, Tsai YG. Hypersensitivity to mosquito bites as the primary clinical manifestation of an Epstein-Barr virus infection. J Microbiol Immunol Infect. 2016;49:613–6.CrossRef Chiu TM, Lin YM, Wang SC, Tsai YG. Hypersensitivity to mosquito bites as the primary clinical manifestation of an Epstein-Barr virus infection. J Microbiol Immunol Infect. 2016;49:613–6.CrossRef
6.
go back to reference Kimura H, Ito Y, Kawabe S, Nakamura S. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673–86.CrossRef Kimura H, Ito Y, Kawabe S, Nakamura S. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673–86.CrossRef
7.
go back to reference Becker JL, Miller F, Nuovo GJ, et al. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest. 1999;104:1673–81.CrossRef Becker JL, Miller F, Nuovo GJ, et al. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest. 1999;104:1673–81.CrossRef
8.
go back to reference Cataudella JA, Young ID, Iliescu EA. Epstein-Barr virus-associated acute interstitial nephritis: infection or immunologic phenomenon? Nephron. 2002;92:437–9.CrossRef Cataudella JA, Young ID, Iliescu EA. Epstein-Barr virus-associated acute interstitial nephritis: infection or immunologic phenomenon? Nephron. 2002;92:437–9.CrossRef
9.
go back to reference Mansur A, Little MA, Oh WC, et al. Immune profile and Epstein-Barr virus infection in acute interstitial nephritis: an immunohistochemical study in 78 patients. Nephron Clin Pract. 2011;119:c293–300.CrossRef Mansur A, Little MA, Oh WC, et al. Immune profile and Epstein-Barr virus infection in acute interstitial nephritis: an immunohistochemical study in 78 patients. Nephron Clin Pract. 2011;119:c293–300.CrossRef
10.
go back to reference Joh K, Kanetsuna Y, Ishikawa Y, et al. Epstein-Barr virus genome-positive tubulointerstitial nephritis associated with immune complex-mediated glomerulonephritis in chronic active EB virus infection. Virchows Arch. 1998;432:567–73.CrossRef Joh K, Kanetsuna Y, Ishikawa Y, et al. Epstein-Barr virus genome-positive tubulointerstitial nephritis associated with immune complex-mediated glomerulonephritis in chronic active EB virus infection. Virchows Arch. 1998;432:567–73.CrossRef
11.
go back to reference Okada H, Ikeda N, Kobayashi T, et al. An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron. 2002;92:440–4.CrossRef Okada H, Ikeda N, Kobayashi T, et al. An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron. 2002;92:440–4.CrossRef
12.
go back to reference Kano K, Yamada Y, Sato Y, et al. Glomerulonephritis in a patient with chronic active Epstein-Barr virus infection. Pediatr Nephrol. 2005;20:89–92.CrossRef Kano K, Yamada Y, Sato Y, et al. Glomerulonephritis in a patient with chronic active Epstein-Barr virus infection. Pediatr Nephrol. 2005;20:89–92.CrossRef
13.
go back to reference Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 1993;118:45–58.CrossRef Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 1993;118:45–58.CrossRef
14.
go back to reference Jackson S, Galla JH, Kirk KA, et al. Epstein-Barr virus transformation of B lymphocytes from IgA nephropathy patients and first-degree relatives results in increased immunoglobulin synthesis not restricted to IgA. Am J Kidney Dis. 1991;17:55–61.CrossRef Jackson S, Galla JH, Kirk KA, et al. Epstein-Barr virus transformation of B lymphocytes from IgA nephropathy patients and first-degree relatives results in increased immunoglobulin synthesis not restricted to IgA. Am J Kidney Dis. 1991;17:55–61.CrossRef
15.
go back to reference Layward L, Allen AC, Harper SJ, Feehally J. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. Exp Nephrol. 1994;2:24–9.PubMed Layward L, Allen AC, Harper SJ, Feehally J. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. Exp Nephrol. 1994;2:24–9.PubMed
16.
go back to reference Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008;118:629–39.PubMedPubMedCentral Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008;118:629–39.PubMedPubMedCentral
17.
go back to reference Iwama H, Horikoshi S, Shirato I, Tomino Y. Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury. Am J Kidney Dis. 1998;32:785–93.CrossRef Iwama H, Horikoshi S, Shirato I, Tomino Y. Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury. Am J Kidney Dis. 1998;32:785–93.CrossRef
18.
go back to reference Asada H. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci. 2007;45:153–60.CrossRef Asada H. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci. 2007;45:153–60.CrossRef
19.
go back to reference Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease. Front Immunol. 2017;8:1867.CrossRef Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease. Front Immunol. 2017;8:1867.CrossRef
20.
go back to reference Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80:64–9.CrossRef Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80:64–9.CrossRef
Metadata
Title
Acute kidney injury in an adult patient with IgA nephropathy and chronic replicative Epstein–Barr virus infection
Authors
Yuya Sato
Kaito Furuyama
Takeshi Suzuki
Tomoyuki Tanaka
Ami Sato
Akira Iguchi
Kazuhiro Yoshita
Yumi Ito
Naofumi Imai
Hajime Yamazaki
Ichiei Narita
Publication date
01-11-2019
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 4/2019
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-019-00409-0

Other articles of this Issue 4/2019

CEN Case Reports 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.